Omidyar Network

Omidyar Network, established in 2004 by eBay founder Pierre Omidyar and his wife Pam, is a global impact investing firm that combines philanthropy and venture capital to catalyze social change. It invests in for-profit and non-profit organizations across sectors such as digital society, emerging technology, education, financial inclusion, governance, and property rights. The firm focuses on early-stage investments, typically committing between $1 million to $10 million in for-profits and $0.5 million to $5 million in non-profits. Omidyar Network operates globally, with a significant focus on India, and seeks to create opportunities for people to improve their lives and make a difference in their communities.

Lauren Booker Allen

Investor

Michael Kubzansky

CEO

Shilpa Kumar

Partner

Annie Maxwell

Executive Vice President

Siddharth Nautiyal

Partner

Past deals in Hospital

HexaHealth

Series A in 2025
HexaHealth is a startup focused on transforming the healthcare landscape by creating a comprehensive network of hospitals nationwide. The company leverages digital solutions to enhance patient care throughout the entire surgical process, addressing the prevalent issue of information asymmetry in the medical field. By utilizing an advanced artificial intelligence-powered recommendation engine, HexaHealth's platform facilitates the identification of suitable doctors and hospitals for patients, ensuring a streamlined experience for hospital admissions, insurance coordination, financing, and post-surgery recovery. This approach not only promotes transparency and accessibility within the medical industry but also empowers patients with the necessary knowledge to make informed decisions regarding their healthcare.

HexaHealth

Seed Round in 2022
HexaHealth is a startup focused on transforming the healthcare landscape by creating a comprehensive network of hospitals nationwide. The company leverages digital solutions to enhance patient care throughout the entire surgical process, addressing the prevalent issue of information asymmetry in the medical field. By utilizing an advanced artificial intelligence-powered recommendation engine, HexaHealth's platform facilitates the identification of suitable doctors and hospitals for patients, ensuring a streamlined experience for hospital admissions, insurance coordination, financing, and post-surgery recovery. This approach not only promotes transparency and accessibility within the medical industry but also empowers patients with the necessary knowledge to make informed decisions regarding their healthcare.

HexaHealth

Seed Round in 2021
HexaHealth is a startup focused on transforming the healthcare landscape by creating a comprehensive network of hospitals nationwide. The company leverages digital solutions to enhance patient care throughout the entire surgical process, addressing the prevalent issue of information asymmetry in the medical field. By utilizing an advanced artificial intelligence-powered recommendation engine, HexaHealth's platform facilitates the identification of suitable doctors and hospitals for patients, ensuring a streamlined experience for hospital admissions, insurance coordination, financing, and post-surgery recovery. This approach not only promotes transparency and accessibility within the medical industry but also empowers patients with the necessary knowledge to make informed decisions regarding their healthcare.

Axio Biosolutions

Series B in 2021
Axio Biosolutions Private Limited is a medical technology company based in Ahmedabad, India, specializing in the development and commercialization of advanced surgical and wound care products. Established in 2007, the company focuses on creating innovative solutions for wound dressings, particularly in pre-hospital emergency care and surgical applications. Its flagship product, AXIOSTAT, is a sterile, non-absorbable haemostatic dressing designed to control bleeding in various traumatic injuries, such as combat and road accidents, as well as surgical procedures. AXIOSTAT is notable for being the first Indian product to receive USFDA clearance for wound care and hemostatic applications. The company primarily serves hospitals, trauma care services, emergency responders, law enforcement, military, and sports officials, addressing the critical need to manage life-threatening bleeding.

Axio Biosolutions

Series B in 2020
Axio Biosolutions Private Limited is a medical technology company based in Ahmedabad, India, specializing in the development and commercialization of advanced surgical and wound care products. Established in 2007, the company focuses on creating innovative solutions for wound dressings, particularly in pre-hospital emergency care and surgical applications. Its flagship product, AXIOSTAT, is a sterile, non-absorbable haemostatic dressing designed to control bleeding in various traumatic injuries, such as combat and road accidents, as well as surgical procedures. AXIOSTAT is notable for being the first Indian product to receive USFDA clearance for wound care and hemostatic applications. The company primarily serves hospitals, trauma care services, emergency responders, law enforcement, military, and sports officials, addressing the critical need to manage life-threatening bleeding.

Amplion Clinical Communications

Seed Round in 2012
Amplion Clinical Communications, Inc. is a Nashville-based company that specializes in developing and implementing wireless patient-care communication technology for hospitals and health systems. Founded in 1979 as Dalcon Communication Systems, the company has evolved significantly over the decades, gaining recognition for technological innovation in healthcare. Amplion offers a comprehensive system known as Amplion Alert, which provides real-time monitoring and communication among caregivers. This system integrates in-room monitoring devices, wireless phones for nurses, and large displays at nurse stations to enhance patient care. It enables caregivers to manage real-time tasks through text messaging, confirm their ability to provide care, and document compliance for reporting purposes. Amplion's solutions are designed to improve the efficiency and effectiveness of patient care by prioritizing tasks and ensuring timely responses to care needs.

OnFocus Healthcare

Series B in 2010
OnFocus Healthcare, originally established in 1985 as m21partners, transformed in 2008 into a provider of business execution software solutions for the healthcare sector. The company specializes in enterprise performance management (EPM) software and support services designed to enhance operational efficiency within healthcare organizations. Its flagship product, onFocus epm™, enables hospitals to improve patient care by streamlining processes, thereby ensuring that care is delivered more efficiently and cost-effectively. Through its software and advisory services, OnFocus Healthcare aims to elevate the performance and execution success of healthcare providers by at least 20%. The company's commitment is to support healthcare executives, managers, and staff in achieving their organizational goals and enhancing overall patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.